Nicotinamide riboside (NR) is one of the most studied NAD+ precursors in longevity research, known for increasing levels of the molecule the body needs for cellular energy production and repair. NAD+ declines with age, linked to reduced organ function and higher disease risk, which is part of why raising it draws so much research interest (1). Our earlier guide, How to Take Nicotinamide Riboside?, covered the basics of standard NR dosing. Liposomal versions are now gaining popularity, so does the format actually change anything, including how much you should take?
What Is Liposomal NR?
Liposomal NR uses the same active ingredient as standard NR; only the delivery method changes. The NR molecule is encapsulated in microscopic phospholipid spheres called liposomes, built from the same material as our own cell membranes. These carriers shield NR from breaking down in the stomach and gut before it reaches the bloodstream.
Does NR Actually Need a Delivery Upgrade?
Liposomal formulations tend to matter most when a compound's main weakness is absorption, which is the case for resveratrol and berberine. A pharmacokinetic study found NR to be uniquely and reliably orally bioavailable in both mice and humans, increasing blood NAD+ by as much as 2.7-fold after a single dose (2). That head start means liposomal encapsulation isn't fixing a broken system. What it may offer instead is protection during digestion, helping a steadier amount of NR reach the bloodstream intact.
Who Might Benefit Most From Liposomal NR?
For the average healthy adult, NR doesn't have an absorption problem to fix, so the choice between liposomal and standard comes down to personal digestion rather than which one works better. A few groups do face documented absorption challenges with other nutrients: long-term use of acid-reducing medications like proton pump inhibitors is linked to lower blood levels of vitamin B12, calcium, and magnesium (3), since stomach acid helps release and dissolve those nutrients for absorption, and stomach acid naturally declines with age. Whether that extends to NR isn't established. NR is already absorbed efficiently through a different route than those nutrients, so it's unclear whether reduced stomach acid affects it the same way, or whether liposomal encapsulation would offer any real advantage in these groups.
For most healthy adults without a digestive condition, standard NR and its liposomal counterpart are both reasonable starting points, and the choice comes down to personal preference, tolerance, and budget rather than documented differences in effectiveness.
What the Research Shows So Far
No published trial has directly compared liposomal NR with standard NR. The closest evidence comes from a 2025 trial on NMN, a related precursor that uses the same NAD+ salvage pathway. After four weeks at 350 mg per day, the liposomal group showed a significantly greater rise in blood NAD+ than the non-liposomal group, which didn't differ significantly from placebo (4). It's a small study, five participants per group, and the findings should be read cautiously until larger trials confirm them. Still, the direction lines up with a broader pattern seen in liposomal vitamin C and glutathione research: encapsulation appears to enhance an already effective absorption process rather than overcome poor absorption (5,6).
How Much Should You Take?
An eight-week randomized, placebo-controlled trial found that 100, 300, and 1,000 mg of NR raised blood NAD+ by 22%, 51%, and 142%, a clear dose-response pattern, with all doses well tolerated (7). A separate six-week trial in middle-aged and older adults confirmed that 1,000 mg daily, taken as 500 mg twice daily, was well tolerated and consistently raised NAD+ metabolism (8).
